Evidence map›Paper›PMID 36460023›Full record

Trial reportThe lancet. HIV2022

Free HIV self-test for identification and linkage to care of previously undetected HIV infection in men who have sex with men in England and Wales (SELPHI): an open-label, internet-based, randomised controlled trial.

Alison J Rodger, Leanne McCabe, Andrew N Phillips, Fiona C Lampe, Fiona Burns, Denise Ward, Valerie Delpech, Peter Weatherburn, T Charles Witzel, Roger Pebody and 9 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The lancet. HIV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Reach and effectiveness outcomes of the "I'm Ready" HIV self-testing program in Black communities in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Promoting STI self-testing through HIV self-testing.Journal of the International AIDS Society · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Alison J RodgerInstitute for Global Health, University College London, London, UK. Electronic address: alison.rodger@ucl.ac.uk.
Leanne McCabeUK MRC Clinical Trials Unit, University College London, London, UK.
Andrew N PhillipsInstitute for Global Health, University College London, London, UK.
Fiona C LampeInstitute for Global Health, University College London, London, UK.
Fiona BurnsInstitute for Global Health, University College London, London, UK.
Denise WardUK MRC Clinical Trials Unit, University College London, London, UK.
Valerie DelpechNational Infection Service, UK Health Security Agency, London, UK.
Peter WeatherburnDepartment of Public Health, London School of Hygiene & Tropical Medicine, London, UK.
T Charles WitzelInstitute for Global Health, University College London, London, UK.
Roger PebodyNAM, London, UK.
Peter KirwanNational Infection Service, UK Health Security Agency, London, UK.
Michelle GabrielUK MRC Clinical Trials Unit, University College London, London, UK.
Jameel KhawamNational Infection Service, UK Health Security Agency, London, UK.
Michael BradyDepartment of Sexual Health and HIV, King's College Hospital, London, UK.
Kevin A FentonDepartment of Health and Social Care, London, UK.
Roy TrevelionHIV i-Base, London, UK.
Yolanda Collaco-MoraesUK MRC Clinical Trials Unit, University College London, London, UK.
Sheena McCormackUK MRC Clinical Trials Unit, University College London, London, UK.
David DunnUK MRC Clinical Trials Unit, University College London, London, UK.
King's College Hospital · GBMRC Clinical Trials Unit at UCL · GBUniversity College London · GBUK Health Security AgencyLondon School of Hygiene & Tropical Medicine · GB

Funding

Department of Health RP-PG-1212-20006Medical Research Council MC_UU_00004/03Medical Research Council MC_UU_12023/23
6 · The paper itself

Abstract

backgroundHigh levels of HIV testing in men who have sex with men remain key to reducing the incidence of HIV. We aimed to assess whether the offer of a single, free HIV self-testing kit led to increased HIV diagnoses with linkage to care.

methodsSELPHI was an internet-based, open-label, randomised controlled trial that recruited participants via sexual and social networking sites. Eligibility criteria included being a man or trans woman (although trans women are reported separately); being resident in England or Wales, UK; being aged 16 years or older; having had anal intercourse with a man; not having a positive HIV diagnosis; and being willing to provide name, email address, date of birth, and consent to link to national HIV databases. Participants were randomly allocated (3:2) by computer-generated number sequence to receive a free HIV self-test kit (BT group) or to not receive this free kit (nBT group). Online surveys collected data at baseline, 2 weeks after enrolment (BT group only), 3 months after enrolment, and at the end of the study. The primary outcome was confirmed (linked to care) new HIV diagnosis within 3 months of enrolment, analysed by intention to treat. Those assessing the primary outcome were masked to allocation. This study is registered with the ISRCTN Clinical Trials Register, number ISRCTN20312003.

findings10 111 participants (6049 in BT group and 4062 in nBT group) enrolled between Feb 16, 2017, and March 1, 2018. The median age of participants was 33 years (IQR 26-44 years); 9000 (89%) participants were White; 8118 (80%) participants were born in the UK; 81 (1%) participants were transgender men; 4706 (47%) participants were university educated; 1537 (15%) participants had never been tested for HIV; and 389 (4%) participants were taking pre-exposure prophylaxis. At enrolment, 7282 (72%) participants reported condomless anal sex with at least one male partner in the previous 3 months. In the BT group, of the 4511 participants for whom HIV testing information was available, 4263 (95%) reported having used the free HIV self-test kit within 3 months.Within 3 months of enrolment there were 19 confirmed new HIV diagnoses (0·31%) in 6049 participants in the BT group and 15 (0·37%) of 4062 in the nBT group (p=0·64).

interpretationThe offer of a single, free HIV self-test did not lead to increased rates of new HIV diagnoses, which could reflect decreasing HIV incidence rates in the UK. Nonetheless, the offer of a free HIV self-testing kit resulted in high HIV testing rates, indicating that self-testing is an attractive testing option for a large group of men who have sex with men.

fundingUK National Institute for Health and Care Research.

Indexed as

HIV InfectionsSexual and Gender MinoritiesAdultFemaleHIV TestingHomosexuality, MaleHumansInternetMaleSelf-TestingSexual BehaviorWales

Identifiers

PMID36460023
PMCPMC7614584
OpenAlexW4310784810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.